Why is Emmessar Biotech falling/rising?

As of 10-Sep, Emmessar Biotech & Nutrition Ltd is experiencing a decline in its stock price, currently at 27.50, which reflects a decrease of 0.12 or 0.43%. The stock has underperformed its sector by 1.01% today and has shown a trend reversal, falling after three consecutive days of gains. Additionally, the stock has seen a significant drop in investor participation, with delivery volume falling by 64.31% compared to the five-day average. Over the past month, the stock has decreased by 3.95%, while its year-to-date performance shows a substantial decline of 40.60%. The stock's performance over the last year is also negative, with a decrease of 32.10%, despite a positive return of 8.70% over the last three years.
In the broader market context, the Sensex has increased by 1.06% over the past week and 1.96% over the past month, contrasting with Emmessar Biotech's negative returns during the same periods. The stock's performance has lagged significantly behind the benchmark, particularly in the year-to-date comparison where the Sensex has gained 4.21%. This underperformance relative to the market may contribute to the stock's current decline, as investors may be reacting to the stock's inability to keep pace with broader market trends and its recent erratic trading behavior.